Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Expression of Toll-like receptors (TLRs) in the lungs of an experimental sepsis mouse model.

Bakopoulos A, Kapelouzou A, Tsilimigras DI, Katsimpoulas M, Schizas D, Aravanis C, Balafas E, Mavroidis M, Pavlakis K, Machairas A, Liakakos T.

PLoS One. 2017 Nov 14;12(11):e0188050. doi: 10.1371/journal.pone.0188050. eCollection 2017.

2.

Identifiable Risk Factors for Lymph Node Metastases in Grade 1 Endometrial Carcinoma.

Pavlakis K, Rodolakis A, Vagios S, Voulgaris Z, Messini I, Yiannou P, Vlachos A, Panoskaltsis T.

Int J Gynecol Cancer. 2017 Oct;27(8):1694-1700. doi: 10.1097/IGC.0000000000001070.

PMID:
28786874
3.

Laparoscopic excision of an inflammatory myofibroblastic tumour of the bladder disguised as deep infiltrating endometriosis.

Koukoura O, Alevra Z, Pavlakis K, Pistofidis G.

BMJ Case Rep. 2017 Jul 14;2017. pii: bcr-2017-220189. doi: 10.1136/bcr-2017-220189.

PMID:
28710194
4.

The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.

Gavressea T, Kalogeras KT, Koliou GA, Zagouri F, Lazaridis G, Gogas H, Tsigaridas K, Koutras A, Petraki K, Markopoulos C, Pazarli E, Aravantinos G, Papadimitriou C, Papakostas P, Koufopoulos N, Karanikiotis C, Chrisafi S, Kalofonos HP, Pectasides D, Fountzilas G, Pavlakis K.

Anticancer Res. 2017 Jun;37(6):2947-2957.

PMID:
28551632
5.

A Novel Experimental Model of Colorectal Endometriosis.

Prodromidou A, Pergialiotis V, Pavlakis K, Korou LM, Frountzas M, Dimitroulis D, Vaos G, Perrea DN.

J Invest Surg. 2017 May 25:1-7. doi: 10.1080/08941939.2017.1317374. [Epub ahead of print]

PMID:
28541751
6.

Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer.

Strati TM, Kotoula V, Kostopoulos I, Manousou K, Papadimitriou C, Lazaridis G, Lakis S, Pentheroudakis G, Pectasides D, Pazarli E, Christodoulou C, Razis E, Pavlakis K, Magkou C, Chrisafi S, Aravantinos G, Bafaloukos D, Papakostas P, Gogas H, Kalogeras KT, Fountzilas G.

Anticancer Res. 2017 May;37(5):2323-2334.

PMID:
28476798
7.

RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.

Giannopoulou L, Chebouti I, Pavlakis K, Kasimir-Bauer S, Lianidou ES.

Oncotarget. 2017 Mar 28;8(13):21429-21443. doi: 10.18632/oncotarget.15249.

8.

Morcellating uterine mesenchymal tumors: The pathologist's view.

Pavlakis K, Messini I, Yiannou P, Gavresea T, Chrysanthakis D, Hilaris G, Panoskaltsis T.

J Obstet Gynaecol Res. 2017 Mar;43(3):580-586. doi: 10.1111/jog.13240. Epub 2017 Jan 25.

PMID:
28120430
9.

Deregulation of p53-MDM2 auto-regulatory pathway in breast carcinoma.

Baliou E, Nonni A, Keramopoulos D, Ragos V, Tsiambas E, Patsouris E, Pavlakis K.

J BUON. 2016 Sept-Oct;21(5):1099-1103.

PMID:
27837610
10.

The Prognostic Value of CD44 Expression in Epithelial-Mesenchymal Transition: Preliminary Data from Patients with Gastric and Esophageal Cancer.

Schizas D, Moris D, Kanavidis P, Michalinos A, Sioulas A, Pavlakis K, Machairas A, Liakakos T.

In Vivo. 2016 11-12;30(6):939-944.

PMID:
27815484
11.

Prevalence of HPV genotypes in cervical adenocarcinoma: a study in Greek women.

Chrysagi A, Kaparos G, Vrekoussis T, Yiannou P, Messini I, Patsouris E, Pavlakis K.

J BUON. 2016 May-Jun;21(3):666-72.

PMID:
27569088
12.

Fractal Dimension as a Diagnostic Tool of Complex Endometrial Hyperplasia and Well-differentiated Endometrioid Carcinoma.

Bikou O, Delides A, Drougou A, Nonni A, Patsouris E, Pavlakis K.

In Vivo. 2016 09-10;30(5):681-90.

PMID:
27566091
13.

Epigenetic mechanisms in endometrial cancer.

Stampoliou A, Arapantoni-Dadioti P, Pavlakis K.

J BUON. 2016 Mar-Apr;21(2):301-6. Review.

PMID:
27273937
14.

Inflammatory myofibroblastic tumor of the small intestine mimicking acute appendicitis: a case report and review of the literature.

Oeconomopoulou A, de Verney Y, Kanavaki K, Stefanaki K, Pavlakis K, Salakos C.

J Med Case Rep. 2016 Apr 19;10:100. doi: 10.1186/s13256-016-0880-0. Review.

15.

Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.

Linardou H, Kalogeras KT, Kronenwett R, Alexopoulou Z, Wirtz RM, Zagouri F, Scopa CD, Gogas H, Petraki K, Christodoulou C, Pavlakis K, Koutras AK, Samantas E, Patsea H, Pectasides D, Bafaloukos D, Fountzilas G.

Anticancer Res. 2015 Jul;35(7):4023-36.

PMID:
26124351
16.

Repeated apneas and hypercapnic ventilatory response before and after apnea training.

Bourdas DI, Tsakiris TS, Pavlakis KI, Triantafillou DV, Geladas ND.

Aerosp Med Hum Perform. 2015 Jan;86(1):27-33. doi: 10.3357/AMHP.3932.2015.

PMID:
25565530
17.

p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumab.

Pavlakis K, Bobos M, Batistatou A, Kotoula V, Eleftheraki AG, Stofas A, Timotheadou E, Pentheroudakis G, Psyrri A, Koutras A, Pectasides D, Papakostas P, Razis E, Christodoulou C, Kalogeras KT, Fountzilas G.

Pathol Oncol Res. 2015 Apr;21(2):273-82. doi: 10.1007/s12253-014-9818-2. Epub 2014 Aug 8.

PMID:
25098276
18.

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type.

Witkowski L, Carrot-Zhang J, Albrecht S, Fahiminiya S, Hamel N, Tomiak E, Grynspan D, Saloustros E, Nadaf J, Rivera B, Gilpin C, Castellsagué E, Silva-Smith R, Plourde F, Wu M, Saskin A, Arseneault M, Karabakhtsian RG, Reilly EA, Ueland FR, Margiolaki A, Pavlakis K, Castellino SM, Lamovec J, Mackay HJ, Roth LM, Ulbright TM, Bender TA, Georgoulias V, Longy M, Berchuck A, Tischkowitz M, Nagel I, Siebert R, Stewart CJ, Arseneau J, McCluggage WG, Clarke BA, Riazalhosseini Y, Hasselblatt M, Majewski J, Foulkes WD.

Nat Genet. 2014 May;46(5):438-43. doi: 10.1038/ng.2931. Epub 2014 Mar 23.

PMID:
24658002
19.

Methylene blue: how to visualize the endometrium in uterine morcellation material.

Pavlakis K, Vrekoussis T, Pistofidis G, Gavresea T, Panoskaltsis T.

Int J Gynecol Pathol. 2014 Mar;33(2):135-9. doi: 10.1097/PGP.0b013e318289437c.

PMID:
24487467
20.

Claudin-3 and claudin-4: distinct prognostic significance in triple-negative and luminal breast cancer.

Kolokytha P, Yiannou P, Keramopoulos D, Kolokythas A, Nonni A, Patsouris E, Pavlakis K.

Appl Immunohistochem Mol Morphol. 2014;22(2):125-31. doi: 10.1097/PAI.0b013e31828d9d62.

PMID:
23702644
21.

Tumor seeding incidentally found two years after robotic-Assisted radical nephrectomy for papillary renal cell carcinoma. A case report and review of the literature.

Ploumidis A, Panoskaltsis T, Gavresea T, Yiannou P, Yiannakou N, Pavlakis K.

Int J Surg Case Rep. 2013;4(6):561-4. doi: 10.1016/j.ijscr.2013.03.031. Epub 2013 Mar 29.

22.

The shotgun proteomic study of the human ThinPrep cervical smear using iTRAQ mass-tagging and 2D LC-FT-Orbitrap-MS: the detection of the human papillomavirus at the protein level.

Papachristou EK, Roumeliotis TI, Chrysagi A, Trigoni C, Charvalos E, Townsend PA, Pavlakis K, Garbis SD.

J Proteome Res. 2013 May 3;12(5):2078-89. doi: 10.1021/pr301067r. Epub 2013 Apr 22.

PMID:
23510160
23.

Three-dimensional ultrasound and three-dimensional power Doppler improve the preoperative evaluation of complex benign ovarian lesions.

Vrachnis N, Sifakis S, Samoli E, Kappou D, Pavlakis K, Iliodromiti Z, Botsis D.

Clin Exp Obstet Gynecol. 2012;39(4):474-8.

PMID:
23444747
24.

Intraneural OX7-saporin for neuroma-in-continuity in a rat model.

Mavrogenis AF, Pavlakis K, Stamatoukou A, Papagelopoulos PJ, Theoharis S, Zetahang Z, Soucacos PN, Zoubos AB.

Eur J Orthop Surg Traumatol. 2013 Apr;23(3):263-72. doi: 10.1007/s00590-012-0996-x. Epub 2012 Apr 27.

PMID:
23412299
25.

Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.

Dionysopoulos D, Pavlakis K, Kotoula V, Fountzilas E, Markou K, Karasmanis I, Angouridakis N, Nikolaou A, Kalogeras KT, Fountzilas G.

Strahlenther Onkol. 2013 Mar;189(3):202-14. doi: 10.1007/s00066-012-0275-0. Epub 2013 Feb 13.

PMID:
23400686
26.

Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.

Katafigiotis I, Tyritzis SI, Stravodimos KG, Alamanis C, Pavlakis K, Vlahou A, Makridakis M, Katafigioti A, Garbis SD, Constantinides CA.

BJU Int. 2012 Dec;110(11 Pt B):E688-93. doi: 10.1111/j.1464-410X.2012.11501.x. Epub 2012 Sep 28.

27.

Her2 negative luminal breast carcinoma and Ki-67 evaluation.

Pavlakis K, Vrekoussis T, Tsipoura A, Tsenga A, Arapantoni-Dadioti P, Gavresea T, Messini I, Barbounis V.

Breast. 2012 Aug;21(4):529-33. doi: 10.1016/j.breast.2012.04.004. Epub 2012 May 28.

PMID:
22647834
28.

Mucinous epithelial lesions in endometrial curettage material: a diagnostic challenge.

Pavlakis K, Vrekoussis T, Messini I, Voulgaris Z, Chrysanthakis D, Yiannou P, Stofas A, Panoskaltsis T.

Appl Immunohistochem Mol Morphol. 2012 Dec;20(6):607-13. doi: 10.1097/PAI.0b013e31825251a4.

PMID:
22531687
29.

Exogenous and autocrine growth factors stimulate human intervertebral disc cell proliferation via the ERK and Akt pathways.

Pratsinis H, Constantinou V, Pavlakis K, Sapkas G, Kletsas D.

J Orthop Res. 2012 Jun;30(6):958-64. doi: 10.1002/jor.22017. Epub 2011 Nov 21.

30.

The prognostic and predictive value of ERCC-1, p53, bcl-2 and bax in epithelial ovarian cancer.

Avraam K, Pavlakis K, Papadimitriou C, Vrekoussis T, Panoskaltsis T, Messini I, Patsouris E.

Eur J Gynaecol Oncol. 2011;32(5):516-20.

PMID:
22053665
31.

Tumor dissemination after laparoscopic surgery for an unsuspected endometrial stromal tumor.

Pavlakis K, Messini I, Papadimitriou CA, Zagouri F, Yiannou P, Mavrelos D, Panoskaltis T.

Eur J Gynaecol Oncol. 2011;32(3):362-3.

PMID:
21797138
32.

Immunohistochemical study of the angiogenetic network of VEGF, HIF1α, VEGFR-2 and endothelial nitric oxide synthase (eNOS) in human breast cancer.

Kafousi M, Vrekoussis T, Tsentelierou E, Pavlakis K, Navrozoglou I, Dousias V, Sanidas E, Tsiftsis D, Georgoulias V, Stathopoulos EN.

Pathol Oncol Res. 2012 Jan;18(1):33-41. doi: 10.1007/s12253-011-9413-8. Epub 2011 Jun 14.

PMID:
21671140
33.

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.

Razis E, Bobos M, Kotoula V, Eleftheraki AG, Kalofonos HP, Pavlakis K, Papakostas P, Aravantinos G, Rigakos G, Efstratiou I, Petraki K, Bafaloukos D, Kostopoulos I, Pectasides D, Kalogeras KT, Skarlos D, Fountzilas G.

Breast Cancer Res Treat. 2011 Jul;128(2):447-56. doi: 10.1007/s10549-011-1572-5. Epub 2011 May 19.

PMID:
21594665
34.

MELF invasion in endometrial cancer as a risk factor for lymph node metastasis.

Pavlakis K, Messini I, Vrekoussis T, Panoskaltsis T, Chrysanthakis D, Yiannou P, Voulgaris Z.

Histopathology. 2011 May;58(6):966-73. doi: 10.1111/j.1365-2559.2011.03802.x. Epub 2011 Mar 25.

PMID:
21438907
35.

Effects of prolonged warm and cold ischemia in a solitary kidney animal model after partial nephrectomy: an ultrastructural investigation.

Tyritzis SI, Zachariades M, Evangelou K, Gorgoulis VG, Kyroudi-Voulgari A, Pavlakis K, Troupis TG, Constantinides CA.

Ultrastruct Pathol. 2011 Apr;35(2):60-5. doi: 10.3109/01913123.2010.542880.

PMID:
21299345
37.

Prognostic factors identifying biochemical recurrence in patients with positive margins after radical prostatectomy.

Anastasiou I, Tyritzis SI, Adamakis I, Mitropoulos D, Stravodimos KG, Katafigiotis I, Balangas A, Kollias A, Pavlakis K, Constantinides CA.

Int Urol Nephrol. 2011 Sep;43(3):715-20. doi: 10.1007/s11255-010-9859-8. Epub 2010 Oct 30.

PMID:
21053071
38.

PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma.

Pavlakis K, Messini I, Vrekoussis T, Panoskaltsis T, Chrissanthakis D, Yiannou P, Stathopoulos EN.

Gynecol Oncol. 2010 Dec;119(3):516-9. doi: 10.1016/j.ygyno.2010.08.023. Epub 2010 Sep 15.

PMID:
20833413
39.

Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group.

Gogas H, Pectasides D, Kostopoulos I, Lianos E, Skarlos D, Papaxoinis G, Bobos M, Kalofonos HP, Petraki K, Pavlakis K, Bafaloukos D, Fountzilas G.

Clin Breast Cancer. 2010 Jun;10(3):230-7. doi: 10.3816/CBC.2010.n.031.

PMID:
20497922
40.

Feasibility, safety, and cost outcomes of laparoscopic management of early endometrial and cervical malignancy.

Hilaris GE, Tsoubis T, Konstantopoulos V, Pavlakis K.

JSLS. 2009 Oct-Dec;13(4):489-95. doi: 10.4293/108680809X12589998403886.

41.

Intraoperative assessment of epithelial and non-epithelial ovarian tumors: a 7-year review.

Pavlakis K, Messini I, Vrekoussis T, Yiannou P, Panoskaltsis T, Voulgaris Z.

Eur J Gynaecol Oncol. 2009;30(6):657-60.

PMID:
20099498
42.

Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model.

Vrekoussis T, Chaniotis V, Navrozoglou I, Dousias V, Pavlakis K, Stathopoulos EN, Zoras O.

Anticancer Res. 2009 Dec;29(12):4995-8.

43.

A pre-tailored panel of antibodies in the study of cervical mesonephric remnants.

Pavlakis K, Messini I, Yiannou P, Chrissanthakis D, Papaspyrou I, Panoskaltsis T, Stathopoulos EN.

Gynecol Oncol. 2010 Mar;116(3):468-72. doi: 10.1016/j.ygyno.2009.10.055. Epub 2009 Nov 14.

PMID:
19913894
44.

Evaluation of routine application of P504S, 34betaE12 and p63 immunostaining on 250 prostate needle biopsy specimens.

Pavlakis K, Stravodimos K, Kapetanakis T, Gregorakis A, Athanassiadou S, Tzaida O, Constantinides C.

Int Urol Nephrol. 2010 Jun;42(2):325-30. doi: 10.1007/s11255-009-9622-1. Epub 2009 Aug 5.

PMID:
19655267
45.

Dynamic spectral imaging: improving colposcopy.

Soutter WP, Diakomanolis E, Lyons D, Ghaem-Maghami S, Ajala T, Haidopoulos D, Doumplis D, Kalpaktsoglou C, Sakellaropoulos G, Soliman S, Perryman K, Hird V, Buckley CH, Pavlakis K, Markaki S, Dina R, Healy V, Balas C.

Clin Cancer Res. 2009 Mar 1;15(5):1814-20. doi: 10.1158/1078-0432.CCR-08-1636. Epub 2009 Feb 17.

46.

Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer.

Makridakis M, Gagos S, Petrolekas A, Roubelakis MG, Bitsika V, Stravodimos K, Pavlakis K, Anagnou NP, Coleman J, Vlahou A.

Proteomics. 2009 Jan;9(2):287-98. doi: 10.1002/pmic.200800121.

PMID:
19105184
47.

Current treatment concepts for neuromas-in-continuity.

Mavrogenis AF, Pavlakis K, Stamatoukou A, Papagelopoulos PJ, Theoharis S, Zoubos AB, Zhang Z, Soucacos PN.

Injury. 2008 Sep;39 Suppl 3:S43-8. doi: 10.1016/j.injury.2008.05.015. Epub 2008 Aug 19. Review.

PMID:
18715561
48.

The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.

Giannopoulos G, Pavlakis K, Parasi A, Kavatzas N, Tiniakos D, Karakosta A, Tzanakis N, Peros G.

Anticancer Res. 2008 May-Jun;28(3B):1875-81.

49.

Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry.

Garbis SD, Tyritzis SI, Roumeliotis T, Zerefos P, Giannopoulou EG, Vlahou A, Kossida S, Diaz J, Vourekas S, Tamvakopoulos C, Pavlakis K, Sanoudou D, Constantinides CA.

J Proteome Res. 2008 Aug;7(8):3146-58. doi: 10.1021/pr800060r. Epub 2008 Jun 14.

PMID:
18553995
50.

Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer.

Sakellariou S, Liakakos T, Ghiconti I, Hadjikokolis S, Nakopoulou L, Pavlakis K.

Anticancer Res. 2008 Mar-Apr;28(2A):1079-83.

Supplemental Content

Loading ...
Support Center